Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment [Member]	Cumulative Effect, Period of Adoption, Adjusted Balance [Member]	Common Stock [Member]	Common Stock [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Additional Paid-In Capital [Member]	Additional Paid-In Capital [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Retained Earnings [Member]	Retained Earnings [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Retained Earnings [Member] Cumulative Effect, Period of Adoption, Adjusted Balance [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Other Comprehensive Income (Loss) [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Unearned ESOP Shares [Member]	Unearned ESOP Shares [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]
Beginning Balance at Dec. 31, 2022	$ 100,182		$ 99,898	$ 74	$ 74	$ 50,161	$ 50,161	$ 56,561		$ 56,277	$ (3,558)	$ (3,558)	$ (3,056)	$ (3,056)
Beginning Balance (in shares) at Dec. 31, 2022				7,394,615	7,394,615
Cumulative change in accounting principle		$ (284)							$ (284)
Net Income	1,015							1,015
Other comprehensive loss	512										512
Share repurchase	(135)					(135)
Share repurchase, (in shares)				(11,843)
ESOP shares earned	37												$ 37
Divended paid	(886)							(886)
Stock-based compensation expense	139					139
Ending Balance at Mar. 31, 2023	100,580			$ 74		50,165		56,406			(3,046)
Ending Balance (in shares) at Mar. 31, 2023				7,382,772									(3,019)
Beginning Balance at Dec. 31, 2023	101,735			$ 71		48,081		59,344			(2,913)		$ (2,848)
Beginning Balance (in shares) at Dec. 31, 2023				7,301,282
Net Income	714							714
Other comprehensive loss	$ (163)										(163)
Net Settlement of common stock options exercised, (in shares)	0
Share repurchase	$ (373)					(373)
Share repurchase, (in shares)				(35,593)
ESOP shares earned	32												32
Divended paid	(876)							(876)
Stock-based compensation expense	264					264
Ending Balance at Mar. 31, 2024	$ 101,333			$ 71		$ 47,972		$ 59,182			$ (3,076)		$ (2,816)
Ending Balance (in shares) at Mar. 31, 2024				7,265,689